Pharma Business Daily
Claim your FREE trial subscription!


Diagnostics:

Therapeutic/Diagnostic Devices for Neurological Disorders

BCC Research
Management Report  March 2007

Paper - USD 4250.00  
Single-user PDF - USD 4850.00  
PDF Site License - USD 5950.00  
PDF Corporate License - USD 8500.00  


Table of Contents

This study examines trends in drug discovery and development for neurodegenerative disorders. Diseases examined include Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), the muscular dystrophies (MD), multiple sclerosis (MS), Parkinson's disease (PD), and Batten disease (BD) and Niemann-Pick disease (NPD), two rare disorders for which treatments exist or are in clinical trials.

It examines medications approved by regulatory agencies as well as candidate drugs in clinical trials. Sponsors range from large companies such as Wyeth to smaller ones, such as PTC Therapeutics and Amorfix. Trends in financing and business approaches are examined, as are strategies for commercializing new products. The report also makes predictions about technologies and approaches that are more or less likely to succeed, and how they are likely to grow in the next 5 years.

The global market for neurological disease treatment and medication was worth $12.6 billion in 2006 and will reach $14 billion by 2007. At a compound annual growth rate (CAGR) of 11.6%, the global market will be worth almost $24.3 billion by 2012. This report contains:
  • An analysis of the trends in drug discovery and development for the neurodegenerative disorders
  • An overview of the global neurological disorders treatment market which provides definitions and a structure for the industry
  • Provides details for the treatment markets of specific diseases such as Alzheimer's, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, muscular dystrophy, and other, rarer neurological disorders
  • Offers a detailed analysis of patents as well as important technological developments
  • A review of government regulations
  • Profiles the most important companies in the industry today.




    • For full details, please email jenniferc@cmsinfo.com

    Order Form



    CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
    Tel:     +44 (0)1494 771734
    Fax:   +44 (0)1494 778994
    e-mail: Jennifer Cowlard
    copyright © 2008 all rights reserved

    For more information about us, visit CMSinfo.

    footer bar